Last reviewed 2026-04-22 · How we verify

Placebo bupropion-Placebo gum

This is a placebo control formulation combining inactive bupropion and placebo gum used in clinical research to assess the efficacy of active bupropion treatment.

This is a placebo control formulation combining inactive bupropion and placebo gum used in clinical research to assess the efficacy of active bupropion treatment. Used for Clinical trial control arm (not a therapeutic indication).

At a glance

Mechanism of action

Placebo bupropion-placebo gum serves as a control arm in clinical trials, allowing researchers to isolate the true therapeutic effect of active bupropion by comparing outcomes against an inert treatment. Since both components are placebos, this formulation produces no pharmacological effect and is used solely for blinding and comparative study purposes.

Approved indications

• Clinical trial control arm (not a therapeutic indication)

Common side effects

No common side effects on file.

Key clinical trials

• Maintenance Treatment for Abstinent Smokers (PHASE3)
• Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke (PHASE4)
• Bupropion Alone or Combined With Nicotine Gum (PHASE4)
• Smoking Relapse Prevention in Schizophrenia (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Placebo bupropion-Placebo gum CI brief — competitive landscape report
• Placebo bupropion-Placebo gum updates RSS · CI watch RSS
• University of Wisconsin, Madison portfolio CI